Venom based neural modulators
- PMID: 29399064
- PMCID: PMC5772594
- DOI: 10.3892/etm.2017.5483
Venom based neural modulators
Abstract
Different types of neuronal nicotinic acetylcholine receptors (nAChRs) are expected to occur in vivo, most structure-activity relationship studies have been carried out for just a few neuronal subtypes. The present review enlightens current aspects of venom modulators of nAChRs. Important electronic databases such as PubMed or Google scholar were explored for the collection of latest studies in the field. Clinical and basic research has shown that cholinergic receptors play a role in several disorders of the nervous system such as chronic pain, Alzheimers disease and addiction to nicotine, alcohol and drugs. Unfortunately, the lack of selective modulators for each subtype of nAChR makes their pharmacological characterization difficult, which has slowed the development of therapeutic nAChR modulators with high selectivity and absence of off-target side-effects. Animal venoms have proven to be an excellent natural source of bioactive molecules with activity against ion channels. The present review concludes that the presence of small-molecule nAChR modulators in spider venoms support the use of venoms as a potential source of novel modulators.
Keywords: nicotinic acetylcholine receptors; venom.
Similar articles
-
Nicotinic receptor modulation to treat alcohol and drug dependence.Front Neurosci. 2015 Jan 15;8:426. doi: 10.3389/fnins.2014.00426. eCollection 2014. Front Neurosci. 2015. PMID: 25642160 Free PMC article. Review.
-
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.J Pharmacol Exp Ther. 1994 Jul;270(1):310-8. J Pharmacol Exp Ther. 1994. PMID: 7518514
-
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.J Pharmacol Exp Ther. 1998 May;285(2):777-86. J Pharmacol Exp Ther. 1998. PMID: 9580626
-
Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment.J Pharmacol Exp Ther. 1998 Aug;286(2):825-40. J Pharmacol Exp Ther. 1998. PMID: 9694939
-
Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation.Front Mol Neurosci. 2015 Nov 25;8:71. doi: 10.3389/fnmol.2015.00071. eCollection 2015. Front Mol Neurosci. 2015. PMID: 26635524 Free PMC article. Review.
References
-
- Mitra S, Mucha M, Khatri SN, Glenon R, Schulte MK, Bult-Ito A. Attenuation of compulsive-like behavior through positive allosteric modulation of α4β2 nicotinic acetylcholine receptors in non-induced compulsive-like mice. Front Behav Neurosci. 2017;10:244. doi: 10.3389/fnbeh.2016.00244. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources